Information Provided By:
Fly News Breaks for May 23, 2017
DRNA
May 23, 2017 | 07:07 EDT
H.C. Wainwright analyst Ed Arce assumed coverage of Dicerna Pharmaceuticals with a Buy rating and $5 price target.
News For DRNA From the Last 2 Days
There are no results for your query DRNA